<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T13:26:12+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>热点解读｜Claudin 18.2-下一个肿瘤免疫治疗 / 伴随诊断新热点</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/s0FCYFwulJ27JLzdlTtyxg</id>
    <link href="https://mp.weixin.qq.com/s/s0FCYFwulJ27JLzdlTtyxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迭代上市的JAK抑制剂</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/v9q8U4W2WOPqTj_vlTmvFQ</id>
    <link href="https://mp.weixin.qq.com/s/v9q8U4W2WOPqTj_vlTmvFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第三款GD2抗体获批上市，对抗儿童癌症之王</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/UB36DDpdPqNtw6pNK8EPaA</id>
    <link href="https://mp.weixin.qq.com/s/UB36DDpdPqNtw6pNK8EPaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华理天团领衔生物药工艺大会，疫情之下，如何顺利参会？</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/XBXdJ8G1S3asfvH6q5azyA</id>
    <link href="https://mp.weixin.qq.com/s/XBXdJ8G1S3asfvH6q5azyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第三款RNAi疗法获批，系首款PH1治疗药物</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/33SqiV8Q-BplDl1gifZksw</id>
    <link href="https://mp.weixin.qq.com/s/33SqiV8Q-BplDl1gifZksw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物医药行业创新风口下，投资者如何选择？</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/A1l67TNXGcvwyO9u_uQPQw</id>
    <link href="https://mp.weixin.qq.com/s/A1l67TNXGcvwyO9u_uQPQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>及时止损？Genmab果断砍掉一款Ⅰ/Ⅱ期 ADC候选产品</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/9ehFReiZ4TTPQekFfBd4GQ</id>
    <link href="https://mp.weixin.qq.com/s/9ehFReiZ4TTPQekFfBd4GQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届华理BIO-ONE大会最终议程，疫情之下，如何顺利参会？尽早安排！</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/4xjd_rFm5mSFJslN-HHwMw</id>
    <link href="https://mp.weixin.qq.com/s/4xjd_rFm5mSFJslN-HHwMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体瘤的突破，首个TCR疗法Ⅲ期临床试验成功</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/eqFeDFB8Fg-eCoEZRQro3w</id>
    <link href="https://mp.weixin.qq.com/s/eqFeDFB8Fg-eCoEZRQro3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 泰尔康医药—共创多肽靶向药物的美好明天</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/s9fDlgPpHzmJdiGU_23tpw</id>
    <link href="https://mp.weixin.qq.com/s/s9fDlgPpHzmJdiGU_23tpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>善变的Th17，顽固的自免疾病</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/I_LmnqCylyR3ZJx4wqL1DA</id>
    <link href="https://mp.weixin.qq.com/s/I_LmnqCylyR3ZJx4wqL1DA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届华理BIO-ONE大会最终议程，疫情之下，如何顺利参会？尽早安排！</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/PYPK1EH-4Ku9U3taEoxXmg</id>
    <link href="https://mp.weixin.qq.com/s/PYPK1EH-4Ku9U3taEoxXmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>本周！2020年中国生物医药产业创新大会与您相聚申城！</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/SSy1HemhUfyIqYKvHTgJvQ</id>
    <link href="https://mp.weixin.qq.com/s/SSy1HemhUfyIqYKvHTgJvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诚益通-制药行业智能制造整体解决方案提供者</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/D7pLBmEPb1nSBqJdGPQbqw</id>
    <link href="https://mp.weixin.qq.com/s/D7pLBmEPb1nSBqJdGPQbqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最终议程 | 疫情之下，还能来顺利参会吗？</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/B3rNiA5nuz7eibnQOCEYrQ</id>
    <link href="https://mp.weixin.qq.com/s/B3rNiA5nuz7eibnQOCEYrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>感恩Biologics——第四届沪上生物医药行业感恩节晚宴</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/e76KCZaftLemc9bP9O8utg</id>
    <link href="https://mp.weixin.qq.com/s/e76KCZaftLemc9bP9O8utg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物TNF-α单抗在中国新适应症获批，治疗多关节型幼年特发性关节炎</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/cZ2Wk71nKDfidjQaCZBr2g</id>
    <link href="https://mp.weixin.qq.com/s/cZ2Wk71nKDfidjQaCZBr2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康&amp;牛津疫苗也来了！平均有效性70%</title>
    <updated>2020-11-23T20:22:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/a3JNjvF1LInRgsRKbap6ww</id>
    <link href="https://mp.weixin.qq.com/s/a3JNjvF1LInRgsRKbap6ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯36|纵览全球药物靶点动态</title>
    <updated>2020-11-22T10:35:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/eAnxmoJDIc13Gb3FZDd7Zg</id>
    <link href="https://mp.weixin.qq.com/s/eAnxmoJDIc13Gb3FZDd7Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何应对生物药大规模生产和厂房建设的挑战？</title>
    <updated>2020-11-22T10:35:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/BpNAxPKvjc9MXQPZEENAyQ</id>
    <link href="https://mp.weixin.qq.com/s/BpNAxPKvjc9MXQPZEENAyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>